Literature DB >> 20124726

Crystallization and preliminary X-ray crystallographic analysis of human FAF1 UBX domain.

Wonchull Kang1, Hwa Young Shin, Jin Kuk Yang.   

Abstract

Fas-associated factor 1 (FAF1) is a multifunctional pro-apoptotic protein that is involved in Fas-mediated apoptosis, NF-kappaB signalling and the ubiquitin-proteasome pathway. In the ubiquitin-proteasome pathway, FAF1 binds to the N domain of p97/VCP, a molecular chaperone that acts in complex with the proteasome, through its C-terminal UBX domain and inhibits the proteasomal protein-degradation process. In an effort to elucidate the structural basis of the function of FAF1 in modulating p97/VCP activity related to proteasomal protein degradation, crystallographic analysis of the FAF1 UBX domain and the p97/VCP N domain was initiated. Following the recently reported crystallization of the FAF1 UBX domain bound to the p97/VCP N domain, the unbound FAF1 UBX domain was also crystallized for purposes of structural comparison. X-ray data were collected to 3.00 A resolution and the crystals belonged to space group F4(1)32, with unit-cell parameters a = b = c = 176.40 A. The Matthews coefficient and solvent content were estimated to be 3.04 A(3) Da(-1) and 59.5%, respectively, assuming that the asymmetric unit contained two molecules of the UBX domain, which was subsequently confirmed by molecular-replacement calculations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20124726      PMCID: PMC2815696          DOI: 10.1107/S1744309110001077

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  19 in total

1.  The Rossmann Fourier autoindexing algorithm in MOSFLM.

Authors:  H R Powell
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-10

2.  The UBX domain: a widespread ubiquitin-like module.

Authors:  A Buchberger; M J Howard; M Proctor; M Bycroft
Journal:  J Mol Biol       Date:  2001-03-16       Impact factor: 5.469

3.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

Review 4.  FAS-associated factor 1 (FAF1): diverse functions and implications for oncogenesis.

Authors:  Craig W Menges; Deborah A Altomare; Joseph R Testa
Journal:  Cell Cycle       Date:  2009-08-16       Impact factor: 4.534

5.  Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.

Authors:  Sílvia Beà; Itziar Salaverria; Lluís Armengol; Magda Pinyol; Verónica Fernández; Elena M Hartmann; Pedro Jares; Virginia Amador; Luís Hernández; Alba Navarro; German Ott; Andreas Rosenwald; Xavier Estivill; Elias Campo
Journal:  Blood       Date:  2008-11-04       Impact factor: 22.113

6.  The pro-apoptotic FAS-associated factor 1 is specifically reduced in human gastric carcinomas.

Authors:  Marina Bjørling-Poulsen; Gerhard Seitz; Barbara Guerra; Olaf-Georg Issinger
Journal:  Int J Oncol       Date:  2003-10       Impact factor: 5.650

7.  Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice.

Authors:  Deborah A Altomare; Craig W Menges; Jianming Pei; Lili Zhang; Kristine L Skele-Stump; Michele Carbone; Agnes B Kane; Joseph R Testa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-17       Impact factor: 11.205

8.  Fas-associated factor-1 inhibits nuclear factor-kappaB (NF-kappaB) activity by interfering with nuclear translocation of the RelA (p65) subunit of NF-kappaB.

Authors:  Min-Young Park; Hyun Duk Jang; Soo Young Lee; Kong-Joo Lee; Eunhee Kim
Journal:  J Biol Chem       Date:  2003-11-04       Impact factor: 5.157

9.  Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma.

Authors:  Alfredo Hidalgo; Michael Baudis; Iver Petersen; Hugo Arreola; Patricia Piña; Guelaguetza Vázquez-Ortiz; Dulce Hernández; José González; Minerva Lazos; Ricardo López; Carlos Pérez; José García; Karla Vázquez; Brenda Alatorre; Mauricio Salcedo
Journal:  BMC Cancer       Date:  2005-07-09       Impact factor: 4.430

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.